• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vertex Pharmaceuticals Inc

+ Add to Watchlist


64.3900 USD 1.1400 1.80%

As of 20:10:00 ET on 04/16/2014.

Snapshot for Vertex Pharmaceuticals Inc (VRTX)

Open: 63.8100 Day's Range: 62.8300 - 64.8200 Volume: 1,459,473
Previous Close: 63.2500 52wk Range: 51.9601 - 89.9600 1-Yr Rtn: +19.14%

Stock Chart for VRTX

No chart data available.
  • VRTX:US 64.3900
  • 1D
  • 1M
  • 1Y
Interactive VRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VRTX

Current P/E Ratio (ttm) 327.9732
Estimated P/E(12/2014) -
Relative P/E vs. SPX 19.0825
Earnings Per Share (USD) (ttm) 0.1963
Est. EPS (USD) (12/2014) -1.9060
Est. PEG Ratio -
Market Cap (M USD) 15,203.29
Shares Outstanding (M) 236.11
30 Day Average Volume 1,665,740
Price/Book (mrq) 11.0982
Price/Sale (ttm) 11.9153
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VRTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VRTX

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.

Jeffrey M LeidenChairman/President/CEOIan F SmithExec VP/CFO
Stuart A ArbuckleExec VP/Chief Commercial OfcrKenneth L Horton "Ken"Exec VP/Chief Legal Officer
More Company Profile & Key Executives for VRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil